Japan, Feb. 18 -- TAISHO PHARMACEUTICAL CO LTD has got intellectual property rights for 'CRYSTALLINE FORM OF UREA COMPOUND ANTAGONIZING LPA1 RECEPTOR, AND PRODUCTION METHOD THEREOF.' Other related details are as follows:
Application Number: JP,2022-010559
Category (FI): C07C273/18,C07C275/26,C07C215/10
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Jan. 27, 2022
Publication Date: Aug. 9, 2022
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....